Vertex Pharmaceuticals Inc (VRTX)

Fixed asset turnover

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	US$ in thousands	10,994,400	9,803,200	8,863,500	7,499,400	6,135,450
Property, plant and equipment	US$ in thousands	1,169,900	886,500	792,900	694,000	527,300
Fixed asset turnover		9.40	11.06	11.18	10.81	11.64

December 31, 2024 calculation

Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $10,994,400K ÷ $1,169,900K
= 9.40

The fixed asset turnover ratio of Vertex Pharmaceuticals Inc has exhibited a generally high level of efficiency in utilizing its fixed assets to generate revenue over the years. The ratio has ranged from 9.40 in December 31, 2024, to a peak of 11.64 in December 31, 2020. Despite fluctuations, the company's ability to efficiently generate sales from its fixed assets remains robust. This indicates that Vertex Pharmaceuticals has effectively managed and utilized its fixed assets to drive revenue generation and operational performance. Overall, the consistent performance of the fixed asset turnover ratio suggests that Vertex Pharmaceuticals has been successful in maximizing the productivity of its fixed assets in creating value for the company.